These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35844621)

  • 21. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
    Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
    Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of KIR
    Di Vito C; Coianiz N; Calvi M; Terzoli S; Zaghi E; Puccio S; Frigo A; Mariotti J; De Philippis C; Mannina D; Sarina B; Mineri R; Le-Trilling VTK; Trilling M; Castagna L; Bramanti S; Santoro A; Mavilio D
    Front Immunol; 2023; 14():1266051. PubMed ID: 38268918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
    Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
    Wu Z; Sinzger C; Frascaroli G; Reichel J; Bayer C; Wang L; Schirmbeck R; Mertens T
    J Virol; 2013 Jul; 87(13):7717-25. PubMed ID: 23637420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral Blood.
    Kovalenko EI; Zvyagin IV; Streltsova MA; Mikelov AI; Erokhina SA; Telford WG; Sapozhnikov AM; Lebedev YB
    Front Immunol; 2020; 11():613882. PubMed ID: 33664730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
    Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D
    J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
    Martínez-Rodríguez JE; Cobo-Calvo A; Villar LM; Munteis E; Blanco Y; Rasal R; Vera A; Muntasell A; Alvarez-Lafuente R; Saiz A; Alvarez-Cermeño JC; Martínez-Yélamos S; Roquer J; López-Botet M
    Mult Scler; 2016 May; 22(6):741-52. PubMed ID: 26362897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kheav VD; Busson M; Scieux C; Peffault de Latour R; Maki G; Haas P; Mazeron MC; Carmagnat M; Masson E; Xhaard A; Robin M; Ribaud P; Dulphy N; Loiseau P; Charron D; Socié G; Toubert A; Moins-Teisserenc H
    Haematologica; 2014 Dec; 99(12):1860-7. PubMed ID: 25085354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.
    Muccio L; Bertaina A; Falco M; Pende D; Meazza R; Lopez-Botet M; Moretta L; Locatelli F; Moretta A; Della Chiesa M
    Haematologica; 2016 Mar; 101(3):371-81. PubMed ID: 26659918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C.
    Kim KH; Yu HT; Hwang I; Park S; Park SH; Kim S; Shin EC
    Front Immunol; 2019; 10():2865. PubMed ID: 31867015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
    Redondo-Pachón D; Crespo M; Yélamos J; Muntasell A; Pérez-Sáez MJ; Pérez-Fernández S; Vila J; Vilches C; Pascual J; López-Botet M
    J Immunol; 2017 Jan; 198(1):94-101. PubMed ID: 27913630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cell maturation markers in the human liver and expansion of an NKG2C+KIR+ population.
    Hydes T; Abuhilal M; Armstrong T; Primrose J; Takhar A; Khakoo S
    Lancet; 2015 Feb; 385 Suppl 1():S45. PubMed ID: 26312867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.
    Bordignon MB; Pesce Viglietti AI; Juliá EP; Sanchez MB; Rölle A; Mandó P; Sabatini L; Ostinelli A; Rizzo MM; Barrio MM; Mordoh J; Fainboim L; Levy EM
    Cancer Immunol Immunother; 2023 Aug; 72(8):2687-2700. PubMed ID: 37081323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.
    Cao K; Marin D; Sekine T; Rondon G; Zhao W; Smith NT; Daher M; Wang Q; Li L; Saliba RM; Pingali R; Popat U; Hosing C; Olson A; Oran B; Basar R; Mehta RS; Champlin R; Shpall EJ; Rezvani K
    Front Immunol; 2018; 9():2444. PubMed ID: 30405633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals.
    Kristensen AB; Wragg KM; Vanderven HA; Lee WS; Silvers J; Kent HE; Grant MD; Kelleher AD; Juno JA; Kent SJ; Parsons MS
    Clin Exp Immunol; 2022 Dec; 210(2):163-174. PubMed ID: 36053502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus.
    Costa-Garcia M; Vera A; Moraru M; Vilches C; López-Botet M; Muntasell A
    J Immunol; 2015 Mar; 194(6):2715-24. PubMed ID: 25667418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.